Literature DB >> 27114735

Effect of aqueous extract of Vernonia amygdalina on atherosclerosis in rabbits.

Omotola Abdulmalik1, Olulola Olutoyin Oladapo2, Modupeola Oluwabunmi Bolaji1.   

Abstract

BACKGROUND: Extracts of Vernonia amygdalina (V. amygdalina) have been shown to affect the serum lipid profile of some laboratory animals in previous studies. Its impact on serum lipid profile and the histological changes in atherosclerosis has not been studied. Our aim was to determine the effects of V. amygdalina on atherosclerotic lesions induced in rabbits on high-cholesterol diet.
METHODS: 18 male rabbits were randomly divided into three groups of control, atherogenic diet, and atherogenic diet + 200 mg/kg of V. amygdalina. The rabbits were fed a normal diet (control group) or a diet supplemented by 0.5% cholesterol and 1% methionine (second and third groups, respectively) for 12 weeks. The fasting sera of all animals were collected at baseline and at the end of the 12 weeks, to determine the levels of lipid profile and the aortas underwent pathomorphological examination.
RESULTS: The two groups on the atherogenic diet had significantly increased serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) compared to the control group. The serum triglyceride (TG) was not statistically different in all three groups. High-density lipoprotein cholesterol (HDL-C) was significantly increased in the V. amygdalina group, compared to the control group but there was no statistically significant difference between the two groups on atherogenic diet. The two groups of rabbits that were on high-cholesterol diet (atherogenic diet group, as well as the atherogenic diet + 200 mg/kg of V. amygdalina) developed histological evidence of atherosclerosis. However, there was no histological difference between the lesions observed in these two groups.
CONCLUSION: The use of 200 mg/kg of aqueous extract of V. amygdalina in rabbits did not appear to exert a significant effect on the serum lipid profile. It also did not appear to have any beneficial effect on the development of atherosclerotic lesions.

Entities:  

Keywords:  Alternative Medicine; Atherosclerosis; Cholesterol; Rabbits; Vernonia

Year:  2016        PMID: 27114735      PMCID: PMC4834179     

Source DB:  PubMed          Journal:  ARYA Atheroscler        ISSN: 1735-3955


  17 in total

Review 1.  Atherosclerosis: current pathogenesis and therapeutic options.

Authors:  Christian Weber; Heidi Noels
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  Efficacy of aqueous leaf extract of vernonia amygdalina on plasma lipoprotein and oxidative status in diabetic rat models.

Authors:  H U Nwanjo
Journal:  Niger J Physiol Sci       Date:  2005 Jun-Dec

3.  Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues.

Authors:  Azar Baradaran
Journal:  J Nephropathol       Date:  2012-10-01

4.  An ethnobotanical study of plants used for the treatment of sexually transmitted diseases (njovhera) in Guruve District, Zimbabwe.

Authors:  L Kambizi; A J Afolayan
Journal:  J Ethnopharmacol       Date:  2001-09       Impact factor: 4.360

5.  The use of herbal preparations for tick control in western Ethiopia.

Authors:  A Regassa
Journal:  J S Afr Vet Assoc       Date:  2000-12       Impact factor: 1.474

6.  Aqueous extract of Piper sarmentosum decreases atherosclerotic lesions in high cholesterolemic experimental rabbits.

Authors:  Adel A Amran; Zaiton Zakaria; Faizah Othman; Srijit Das; Santhana Raj; Nor-Anita M M Nordin
Journal:  Lipids Health Dis       Date:  2010-04-30       Impact factor: 3.876

Review 7.  Antioxidative and chemopreventive properties of Vernonia amygdalina and Garcinia biflavonoid.

Authors:  Ebenezer O Farombi; Olatunde Owoeye
Journal:  Int J Environ Res Public Health       Date:  2011-06-23       Impact factor: 3.390

8.  Changes of blood biochemistry in the rabbit animal model in atherosclerosis research; a time- or stress-effect.

Authors:  Ismene A Dontas; Katerina A Marinou; Dimitrios Iliopoulos; Nektaria Tsantila; George Agrogiannis; Apostolos Papalois; Theodore Karatzas
Journal:  Lipids Health Dis       Date:  2011-08-14       Impact factor: 3.876

9.  Frequency of complementary and alternative medicine utilization in hypertensive patients attending an urban tertiary care centre in Nigeria.

Authors:  Oluwatoyin C Amira; Njideka U Okubadejo
Journal:  BMC Complement Altern Med       Date:  2007-09-28       Impact factor: 3.659

10.  Lipid-lowering effects of methanolic extract of Vernonia amygdalina leaves in rats fed on high cholesterol diet.

Authors:  Oluwatosin A Adaramoye; Olajumoke Akintayo; Jonah Achem; Michael A Fafunso
Journal:  Vasc Health Risk Manag       Date:  2008
View more
  1 in total

1.  IMMUNO-MODULATORY PROPERTIES OF PREBIOTICS EXTRACTED FROM vernonia amygdalina.

Authors:  Ezeonu Im; Asuquo Ae; Ukwah Bn; Ukoha Po
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-09-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.